IRISanRaf

MUSELLA, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.302
AS - Asia 1.499
EU - Europa 387
SA - Sud America 175
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 5
Totale 4.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.037
TR - Turchia 475
SG - Singapore 422
CN - Cina 410
CA - Canada 249
IT - Italia 216
BR - Brasile 141
VN - Vietnam 82
DE - Germania 52
HK - Hong Kong 32
EU - Europa 28
GB - Regno Unito 19
FI - Finlandia 18
IN - India 16
AR - Argentina 14
SC - Seychelles 13
RU - Federazione Russa 12
IE - Irlanda 11
JP - Giappone 11
BD - Bangladesh 10
SE - Svezia 10
IQ - Iraq 9
MX - Messico 9
PL - Polonia 9
EC - Ecuador 7
ES - Italia 7
NL - Olanda 7
ZA - Sudafrica 7
ID - Indonesia 6
FR - Francia 5
UA - Ucraina 5
AU - Australia 4
CH - Svizzera 4
EG - Egitto 4
KR - Corea 4
NP - Nepal 4
UZ - Uzbekistan 4
BO - Bolivia 3
CL - Cile 3
CO - Colombia 3
IR - Iran 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DZ - Algeria 2
IL - Israele 2
LT - Lituania 2
MA - Marocco 2
PK - Pakistan 2
SA - Arabia Saudita 2
TN - Tunisia 2
VE - Venezuela 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
MD - Moldavia 1
ML - Mali 1
MR - Mauritania 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.430
Salva come PNG Salva come JPEG
Città #
Dallas 514
San Mateo 448
Kocaeli 401
Toronto 227
Wilmington 113
Singapore 106
Ashburn 105
Santa Clara 104
Houston 84
Beijing 83
Lawrence 78
Princeton 78
Chandler 54
Los Angeles 41
Shanghai 41
Rome 38
Ho Chi Minh City 33
Hong Kong 30
Guangzhou 23
Frankfurt am Main 22
Seattle 19
The Dalles 19
Fairfield 18
Hanoi 18
São Paulo 17
Woodbridge 16
Columbus 15
Shenzhen 14
New York 13
Brooklyn 12
Turku 10
West Jordan 10
Falls Church 9
Tokyo 9
Boston 8
Cambridge 8
Helsinki 8
Warsaw 8
Jiaxing 7
Milan 7
Chicago 6
London 6
Montreal 6
Rui'an 6
San Francisco 6
Wuxi 6
Atlanta 5
Boardman 5
Da Nang 5
Stockholm 5
Viggiù 5
Xi'an 5
Amsterdam 4
Biên Hòa 4
Chennai 4
Council Bluffs 4
Florence 4
Guayaquil 4
Johannesburg 4
Las Vegas 4
Palermo 4
Phoenix 4
Pune 4
Redwood City 4
Seoul 4
Wuhan 4
Ankara 3
Belo Horizonte 3
Bern 3
Dongyang 3
Haiphong 3
Kemerovo 3
Lariano 3
Mexico City 3
Munich 3
Salt Lake City 3
São Gonçalo 3
Taizhou 3
Tashkent 3
Xuzhou 3
Afogados da Ingazeira 2
Al Qahirah al Jadidah 2
Alessandria 2
Andover 2
Bengbu 2
Berlin 2
Brampton 2
Brasília 2
Buffalo 2
Campinas 2
Campos dos Goytacazes 2
Charleston 2
Charlotte 2
Chengdu 2
Città di Castello 2
Curvelo 2
Dhaka 2
Dublin 2
Franca 2
Guarulhos 2
Totale 3.072
Salva come PNG Salva come JPEG
Nome #
4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity 343
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 93
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 80
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 76
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 68
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 67
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 66
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 64
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 64
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 62
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 60
Linking synaptopathy and gray matter damage in multiple sclerosis 58
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis 58
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 57
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 57
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum 57
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 56
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 56
Behavioral and electrophysiological effects of endocannabinoid and dopaminergic systems on salient stimuli 55
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 55
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 55
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis 54
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis 54
Before or after does it matter? Different protocols of environmental enrichment differently influence motor, synaptic and structural deficits of cerebellar origin 54
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 53
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects 53
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 53
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 53
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. 52
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 51
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis 50
Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis 50
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 50
Obesity worsens central inflammation and disability in multiple sclerosis 50
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 50
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 50
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis 49
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 49
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 48
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 48
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 48
Adaptations of striatal endocannabinoid system during stress 48
TRPV1 channels facilitate glutamate transmission in the striatum 48
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 48
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 48
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 47
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 47
Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis 46
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 46
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 45
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 44
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 44
MiR-142-3p is a key regulator of IL-1β-dependent synaptopathy in neuroinflammation 44
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 44
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum 43
Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis 42
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 42
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 42
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 42
Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake 42
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 42
Interleukin-1β causes anxiety by interacting with the endocannabinoid system 40
Adaptations of glutamatergic synapses in the striatum contribute to recovery from cerebellar damage 40
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 39
Cerebellar control of cortico-striatal LTD 39
Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study 38
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum 38
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 38
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 38
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 37
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 37
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 37
Differences in spontaneously avoiding or approaching mice reflect differences in CB1-mediated signaling of dorsal striatal transmission 37
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 37
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 36
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 36
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors 35
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 35
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis 33
Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum 33
Preventive exercise and physical rehabilitation promote long‐term potentiation‐like plasticity expression in patients with multiple sclerosis 32
Electrophysiology of Endocannabinoid Signaling 30
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 27
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 27
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 26
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 24
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 22
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis 21
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 21
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity 18
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis 18
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 18
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation 17
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 16
Special Issue Title: The neuroimmune crosstalk in mood disturbances of neurological and psychiatric diseases 15
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis 14
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients 12
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 4
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 3
IL-1β contributes to neurological disability in NMOSD AQP4 + Patients 3
Totale 4.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021535 0 0 0 0 0 25 33 9 16 13 403 36
2021/2022871 2 222 232 4 6 8 34 92 20 226 19 6
2022/2023306 179 4 4 19 8 14 0 9 10 19 23 17
2023/2024226 4 6 8 41 6 14 1 12 0 37 0 97
2024/20251.002 50 160 103 56 37 145 65 48 145 22 39 132
2025/20261.353 155 248 479 199 268 4 0 0 0 0 0 0
Totale 4.593